Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

RUNA - Repositorio de Saúde

redirect
Last time updated on 20/03/2020

This paper was published in RUNA - Repositorio de Saúde.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.